BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Angiomax: Pilot trial data

A pilot trial as part of the BRAVO program in 428 patients with severe aortic stenosis undergoing balloon valvuloplasty (BAV) via transfemoral access showed that adjunctive therapy with Angiomax led to a 60% reduction in the rate of in-hospital major bleeding...

Read the full 184 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >